This is the authors' abstract. We don't add key points for this paper.
Six consecutive patients with rapid-cycling bipolar disorder, refractory or only minimally responsive to treatment with lithium salts and neuroleptics, including five also refractory to carbamazepine, all demonstrated a moderate or marked response to the anticonvulsant valproate. These observations suggest that valproate may represent a promising treatment alternative in this often treatment-resistant form of bipolar disorder.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
McElroy et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: